Earnings call transcript: Columbia Banking System Q1 2026 results show strong EPS beat

COLB is now in the less obvious part of the integration story: the market will stop paying for “execution” and start underwriting repeatable operating leverage. The key second-order effect is that the bank is converting a one-time M&A event into a durable funding-cost and mix benefit by shrinking wholesale dependence while retaining/repricing transactional balances into higher-relationship assets; that combination can support margin even if absolute loan growth stays flat. In other words, the earnings bridge is increasingly self-funded by mix, not balance-sheet expansion, which makes the path to higher EPS less macro-sensitive than most regionals.

The real surprise is not the beat itself but the optionality embedded in capital return. If management executes the planned buyback cadence while CET1 is already comfortably above the target range, the share count can keep falling faster than consensus models, creating a mechanical EPS tailwind that doesn’t require multiple expansion. That matters because regional bank multiples usually rerate only on clean credit trends or visible growth inflection; COLB may be able to grind higher without either, simply by compounding ROTCE and shrinking the float.

The main risk is that investors extrapolate the current margin trajectory and ignore the lagged cost of deposit competition and the possibility that the transactional runoff becomes more persistent than management assumes. If the bank has to pay up to retain funding or if credit noise in agriculture widens beyond idiosyncratic cases, the market will quickly reprice the story from “integration beneficiary” to “mature regional with fading temporary boosts.” The timing window is important: near-term upside is a 1-2 quarter story on synergies and buybacks, while the real test comes into 2027 when the runoff math becomes harder and growth must reaccelerate on a clean base.

Consensus may be underestimating how much of the franchise is being de-risked by the deliberate shift away from low-return, rate-sensitive balances. That improves earnings quality and should compress perceived downside in a downturn, but it also means the stock may be better suited to a modest premium on steady compounding rather than a full growth-bank multiple. The contrarian angle is that the best trade may not be chasing upside after the print; it may be using strength to own the name as a capital-return compounder while hedging the broader regional-bank beta.